Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
β-Aminopropionitrile
Cat. No.:
OB0425LY-412
Appearance:
Liquid
Purity:
99.2%
Identity:
Confirmed by NMR and GC.
Size:
Add to basket
Product Overview
Description:
β-Aminopropionitrile is an irreversible and orally active lysyl oxidase (LOX) inhibitor and inhibits the crosslinking of collagen.
Synonyms:
3-Aminopropionitrile; 151-18-8; 2-Cyanoethylamine; Aminopropionitrile;Propanenitrile, 3-amino-; BAPN; beta-Cyanoethylamine; 3-Aminopropiononitrile; beta-Alaninenitrile; Propionitrile, 3-amino-
CAS No.:
151-18-8
Compound CID:
1647
Formula:
C3H6N2
Formula Weight:
70.09
Specification
Target:
Monoamine oxidase; Endogenous metabolite
Pathway:
Neuronal signaling; Metabolic enzyme/Protease
Solubility:
DMSO, Water
Density:
0.9584 g/cm3
Storage:
Storage at -20°C.
Applications:
β-Aminopropionitrile can be used in studying conditions related to connective tissue disorders. It is also investigated for its potential role in cancer research.
